Cargando…

Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study

PURPOSE: The aim of this study was to analyze data on gabapentinoid-related attendances to the National Poison Control Center of Serbia (NPCC), particularly abuse cases; to estimate its changes and to compare it with trends in national consumption rates of these drugs. We also aimed to analyze the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunovic, Marko, Vucinic, Slavica, Kotur-Stevuljevic, Jelena, Krstic, Kristijan, Jovic-Stosic, Jasmina, Kilibarda, Vesna, Perkovic-Vukcevic, Natasa, Djordjevic, Snezana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094400/
https://www.ncbi.nlm.nih.gov/pubmed/37065979
http://dx.doi.org/10.2147/IJGM.S405616
_version_ 1785023832747147264
author Antunovic, Marko
Vucinic, Slavica
Kotur-Stevuljevic, Jelena
Krstic, Kristijan
Jovic-Stosic, Jasmina
Kilibarda, Vesna
Perkovic-Vukcevic, Natasa
Djordjevic, Snezana
author_facet Antunovic, Marko
Vucinic, Slavica
Kotur-Stevuljevic, Jelena
Krstic, Kristijan
Jovic-Stosic, Jasmina
Kilibarda, Vesna
Perkovic-Vukcevic, Natasa
Djordjevic, Snezana
author_sort Antunovic, Marko
collection PubMed
description PURPOSE: The aim of this study was to analyze data on gabapentinoid-related attendances to the National Poison Control Center of Serbia (NPCC), particularly abuse cases; to estimate its changes and to compare it with trends in national consumption rates of these drugs. We also aimed to analyze the main characteristics of the study population and to investigate the major clinical effects in poisoned patients. PATIENTS AND METHODS: This is a retrospective study of patients admitted to the NPCC for acute poisoning involving gabapentinoids from 1 May 2012 to 1 October 2022. RESULTS: There were 357 (95.5%) pregabalin-related and 17 (4.5%) gabapentin-related poisoning cases in 302 patients. Abuse of pregabalin was detected in 27.8% (84/302), while gabapentin abuse occurred in 0.7% (2/302) of all patients. A steady increase in rates of pregabalin poisoning and abuse cases strongly correlated with the increase in overall consumption of this drug, while there were no significant changes in rates of gabapentin consumption, poisoning and abuse rate during the study period. Most patients who abused pregabalin pregabalin were males (84.5%) and the median age was 26 years (range: 15–45 years). Almost 60% of patients who abused pregabalin (48/84) belonged to the migrant population. Co-ingestions occurred in 89.4% of pregabalin-related cases (319/357), resulting in more severe poisoning. The most often co-ingested drugs were benzodiazepines and among them clonazepam was detected in the largest number of cases. CONCLUSION: The poisoning and abuse cases involving pregabalin are on the rise in Serbia, which coincided with an increase in its overall consumption during the study period. Isolated pregabalin ingestions resulted in mild poisoning, although severe symptoms such as coma and bradycardia were recorded. When prescribing pregabalin to patients at risk of abuse caution is needed. Strengthening the measures for dispensing of pregabalin may reduce the risks associated with its abuse.
format Online
Article
Text
id pubmed-10094400
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100944002023-04-13 Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study Antunovic, Marko Vucinic, Slavica Kotur-Stevuljevic, Jelena Krstic, Kristijan Jovic-Stosic, Jasmina Kilibarda, Vesna Perkovic-Vukcevic, Natasa Djordjevic, Snezana Int J Gen Med Original Research PURPOSE: The aim of this study was to analyze data on gabapentinoid-related attendances to the National Poison Control Center of Serbia (NPCC), particularly abuse cases; to estimate its changes and to compare it with trends in national consumption rates of these drugs. We also aimed to analyze the main characteristics of the study population and to investigate the major clinical effects in poisoned patients. PATIENTS AND METHODS: This is a retrospective study of patients admitted to the NPCC for acute poisoning involving gabapentinoids from 1 May 2012 to 1 October 2022. RESULTS: There were 357 (95.5%) pregabalin-related and 17 (4.5%) gabapentin-related poisoning cases in 302 patients. Abuse of pregabalin was detected in 27.8% (84/302), while gabapentin abuse occurred in 0.7% (2/302) of all patients. A steady increase in rates of pregabalin poisoning and abuse cases strongly correlated with the increase in overall consumption of this drug, while there were no significant changes in rates of gabapentin consumption, poisoning and abuse rate during the study period. Most patients who abused pregabalin pregabalin were males (84.5%) and the median age was 26 years (range: 15–45 years). Almost 60% of patients who abused pregabalin (48/84) belonged to the migrant population. Co-ingestions occurred in 89.4% of pregabalin-related cases (319/357), resulting in more severe poisoning. The most often co-ingested drugs were benzodiazepines and among them clonazepam was detected in the largest number of cases. CONCLUSION: The poisoning and abuse cases involving pregabalin are on the rise in Serbia, which coincided with an increase in its overall consumption during the study period. Isolated pregabalin ingestions resulted in mild poisoning, although severe symptoms such as coma and bradycardia were recorded. When prescribing pregabalin to patients at risk of abuse caution is needed. Strengthening the measures for dispensing of pregabalin may reduce the risks associated with its abuse. Dove 2023-04-08 /pmc/articles/PMC10094400/ /pubmed/37065979 http://dx.doi.org/10.2147/IJGM.S405616 Text en © 2023 Antunovic et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Antunovic, Marko
Vucinic, Slavica
Kotur-Stevuljevic, Jelena
Krstic, Kristijan
Jovic-Stosic, Jasmina
Kilibarda, Vesna
Perkovic-Vukcevic, Natasa
Djordjevic, Snezana
Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study
title Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study
title_full Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study
title_fullStr Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study
title_full_unstemmed Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study
title_short Rise of Pregabalin Poisoning and Abuse Cases in Serbia: A Ten-Year Retrospective Study
title_sort rise of pregabalin poisoning and abuse cases in serbia: a ten-year retrospective study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094400/
https://www.ncbi.nlm.nih.gov/pubmed/37065979
http://dx.doi.org/10.2147/IJGM.S405616
work_keys_str_mv AT antunovicmarko riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy
AT vucinicslavica riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy
AT koturstevuljevicjelena riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy
AT krstickristijan riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy
AT jovicstosicjasmina riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy
AT kilibardavesna riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy
AT perkovicvukcevicnatasa riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy
AT djordjevicsnezana riseofpregabalinpoisoningandabusecasesinserbiaatenyearretrospectivestudy